INcreaSed WhIte cell couNtS compiled by dr N holland JulY 2012
This newsletter deals with an approach to increased toxic granulation and vacuolation, the presence white cell counts. All reference levels mentioned
of dohle bodies and left shift. Rarely, organisms
can be visualised within the neutrophils. In cases which are not clear, reactive markers such as CRP,
Is an increased white blood cell count a clonal
procalcitonin and ESR may be useful in confirming
(malignant) or reactive increase?
This question is often asked, and in most cases
tissue infarction/necrosis
the increase is reactive in nature. But be aware of the possibility of malignancy so that a potential y
For example, myocardial infarction, burns and
serious condition is not overlooked.
When a raised white cell count is detected, the
chronic inflammation
differential count should always be evaluated to determine the significance of the high count. If
Numerous chronic inflammatory conditions can be
the raised count is due to the presence of blasts
associated with chronic neutrophilia, for example,
or primitive mononuclear cel s, particularly with
associated cytopaenias, urgent evaluation by a haematologist is necessary.
drugs and toxins NeutrophIlIa
A neutrophilia is one of the most common abnormal findings on the full blood count. This is defined as
• Growth factor administration: e.g. neupogen
a neutrophil count greater than 8x109/l. There are
numerous reactive causes of neutrophilia:
Steroid/stress response
• Chronic cigarette smoking: common cause of
Conditions associated with steroid and stress-
hormone release can cause a rapid, usual y transient, neutrophilia, for example, pain, exercise,
underlying carcinoma or lymphoma
seizures and emotional stress such as anger. This is primarily the result of redistribution of cel s from
Certain carcinomas, particularly adenocarcinomas
vascular beds (e.g. the spleen) to the circulating
that have metastasised, can result in raised
neutrophil counts, possibly through release of growth factors. This can be a cause of particularly
Infection
Bacterial infection, particularly, is a common
More rarely lymphomas, for example Hodgkin’s
cause of neutrophilia. Associated changes to
lymphoma, may stimulate a reactive increase in
the neutrophil morphology may be noted on
review of the peripheral smear. These include
less common causes
• Persistent neutrophilia may be detected post-
Vasculitides and connective tissue disease are less
common causes. In the case of malignant disease eosinophilia may be reactive to underlying non-
haemopoietic tumours or lymphoma (e.g. Hodgkin’s lymphoma). Clonal T cell populations have been
• Rebound fol owing agranulocytosis.
identified in a subset of patients with otherwise unexplained eosinophilia. clonal/malignant increase in the neutrophil count clonal causes of eosinophilia
This is far more rare than reactive causes. A clonal
These are uncommon. Clonal eosinophilia may
increase in a differentiated myeloid cel , such as
be seen in the context of myeloid and lymphoid
the neutrophil, may occur in the myeloproliferative
neoplasms. Reactive causes should be excluded.
neoplasms. Findings that may increase suspicion
In certain cases no reactive cause or evidence of
of a myeloid malignancy include the presence of
clonality can be identified to explain a persistent
a significant left shift (neutrophil precursors in the
eosinophilia. These cases have been label ed as
peripheral blood), an associated increase in the
idiopathic hypereosinophilic syndrome. This is an
basophil count, normal reactive markers, increased
unexplained eosinophilia of >1.5x109/l that lasts for
patient age, very high white cell counts (although
there is no absolute cut off to distinguish reactive from clonal states), the presence of splenomegaly
BaSophIlIa
and accompanying thrombocytosis and/or polycythaemia. If there is concern, review of the
This is a basophil count greater than 0.2x109/l.
An increase in the basophil count can be noted in al ergy and in inflammatory conditions such as
eoSINophIlIa
ulcerative colitis. Viral infection, notably chickenpox and influenza, may have an associated basophilia.
An eosinophilia is defined as an eosinophil count above 0.5x109/l. A wide range of conditions can
Basophilia can be seen in clonal myeloid disorders.
be associated with eosinophilia, some common,
Importantly, CML (chronic myeloid leukaemia) is
others less so. Eosinophilia may be reactive to
almost invariably associated with an increase in
an underlying condition or clonal (i.e. represent
the basophil count. This can provide a clue to the
part of a malignant clone). A persistent significant
diagnosis in patients with a neutrophil leucocytosis
eosinophilia can result in end organ infiltration and
damage. The causes of eosinophilia are as fol ows:
MoNocYtoSIS parasitic infection
A monocytosis is defined as a blood monocyte
This is the most common cause of eosinophilia
count greater than 1x109/l. An acute mild increase
worldwide. Helminthic parasitic infestation is a
in the monocyte count can be recorded fol owing
particularly common cause and can be associated
acute physical and/or emotional stress (probably
with very high while blood cell counts.
secondary to catecholamine release). This is as a result of demargination (redistribution from
allergic disease
areas such as spleen, pulmonary capil aries). The increase is transient and is mirrored by an increase
In the developed world, eosinophilia is more
frequently seen secondary to atopic disease such as seasonal rhinitis, asthma and atopic dermatitis.
A sustained increase is more significant. Conditions associated with monocytosis include infectious
drug reaction
and other inflammatory disorders and malignant disease. A monocytosis can be reactive to the
Many drugs may be implicated and the eosinophil
malignant disease or may be part of the abnormal
count returns to normal once the drug has
clone. Reactive causes will be discussed first.
been withdrawn. The drugs often involved are carbamazepine and minocycline.
Infection
• Subacute/chronic: tuberculosis, bacterial
• Chronic inflammation can result in a
persistent increase, e.g. autoimmune disease
Inflammatory conditions
• Hypersensitivity reactions: drug reactions,
Col agen vascular disease: systemic lupus erythematosus, rheumatoid arthritis etc. reactive to underlying malignancy
• Stress (acute) lymphocytosis: similar causes
Monocytosis may be a marker of underlying malignancy and a reactive increase is seen in up
Malignant/Monoclonal lymphocytosis
Clinical features which can suggest a lympho-
Up to 25% of Hodgkin’s lymphoma is associated
proliferative disorder include lymphadenopathy,
with a monocytosis. It can also be noted in other
hepatomegaly or splenomegaly, an isolated mass
lymphoproliferative disorders including multiple
or findings such as unexplained skin lesions. If the
morphology is unhelpful, the lymphocytosis persists or the clinical suspicion is high, flow cytometric
analysis can be performed on a peripheral blood sample. This al ows more definitive assessment of
neutropaenia or the early stages of drug-induced agranulocytosis may be
B cel /T cell and NK cell lymphoproliferative
disorders can be associated with a lymphocytosis. clonal increase in monocytes (haemopoietic malignancy)
An increase in monocytes may be seen in certain acute myeloid leukaemias and chronic disorders such as particular myeloproliferative neoplasms and myelodysplastic syndromes. In some situations the monocyte count may be very high. Peripheral blood findings, including the presence of cytopaenias and clinical features such as splenomegaly provide valuable clues in the investigation of an unexplained monocytosis. Assessment of inflammatory markers (e.g. CRP) should be considered. In certain cases a bone marrow investigation will be of value. lYMphocYtoSIS
This is an absolute lymphocyte count of greater than 4x109/l. The increase may be reactive (polyclonal) or monoclonal. Clinical history and thorough physical examination, as well as
assessment of the peripheral smear, are useful in differentiating between these two states.
The presence of a population of blasts or primitive mononuclear cel s in the blood is usual y a cause
reactive causes of lymphocytosis
for concern. Please note that circulating blasts can be seen in the context of a reactive neutrophil left
• Infectious mononucleosis type syndromes:
shift, but the number is usual y small in comparison
Epstein-Barr virus, cytomegalovirus, HIV,
to the presence of maturing granulocytic elements.
If blasts or an abnormal primitive population are identified in the peripheral blood, flow cytometric analysis can be performed on this sample to further characterise the cel s.
coNcluSIoN
The presence of a raised white cell count should not be assessed in isolation. The component of the differential that is increased should be established. The presence of cytopaenias or other cytoses may provide additional information. Assessment of the peripheral blood smear by a haematologist or an experienced technologist may be of value in situations in which the cause of the increased count is not clear. Clinical y, hepatosplenomegaly, lymphadenopathy and other abnormal masses should be excluded. In certain situations, a bone marrow investigation may be required. When an unexplained lymphocytosis is detected or blasts are present in the peripheral blood, flow cytometric analysis can be performed on a peripheral blood sample to investigate a possible haemopoietic/lymphoid malignancy. references
Hoffbrand AV, Catovsky D & Tuddenham EGD (2005) Postgraduate Haematology, 5th edition. Blackwell Publishing. Oxford.
Beutler E, Lichtman M, Col er BS, Kipps TJ & Seligsohn U (2001) Wil iams Hematology, 6th edition. McGraw-Hil , Medical Publishing Division. New York. head offIce
Lancet Corner, Ground Floor, Cnr Menton and Stanley Roads, Richmond, Johannesburg, (011) 358 0800
pretorIa MaIN laBoratorY
1st Floor Pencardia Building, 509 Pretorius Street, Arcadia, (012) 483 0100
durBaN MaIN laBoratorY
102 Lancet Medical Centre, 74 Lorne Street, Durban, (031) 308 6500
www.lancet.co.za @ lancetlab
Medroxy-Progesteron-Azetat (MPA) in Lebensmitteln Was ist Medroxy-Progesteron-Azetat (MPA)? MPA ist ein synthetisch hergestelltes Sexualhormon. Es ist ein Abkömmling des weiblichen Gelbkörperhormons Progesteron. MPA zählt zur Gruppe der Gestagene. Diese kontrollieren die Einnistung und Entwicklung des Embryos im Uterus. Synthetische Produkte wie MPA wirken stärker als natü
Univ. Doz. Dr. Willibald Gerschlager Krankenhaus der Barmherzigen Brüder Neurologische Abteilung 1020 Wien PUBLIKATIONSLISTE ERSTAUTORSCHAFTEN 1) Gerschlager W. Kurzfassung der Dissertation: In-vivo Studie über den Einfluß vonNeurotransmittern auf den Gefäßtonus. Wien Klin Wochenschr 1994;106:531-533. (Impact Factor: 0.3 ). 2) Gerschlager W, Lalouschek W, Lehrner J, Baumgartner